- Home
- VMEO vs AORT Comparison
VMEO vs AORT Comparison
Compare VMEO & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMEO
- AORT
- Stock Information
- Founded
- VMEO 2004
- AORT 1984
- Country
- VMEO United States
- AORT United States
- Employees
- VMEO N/A
- AORT N/A
- Industry
- VMEO Computer Software: Prepackaged Software
- AORT Medical/Dental Instruments
- Sector
- VMEO Technology
- AORT Health Care
- Exchange
- VMEO Nasdaq
- AORT Nasdaq
- Market Cap
- VMEO 756.2M
- AORT 1.4B
- IPO Year
- VMEO N/A
- AORT 1993
- Fundamental
- Price
- VMEO $3.92
- AORT $30.84
- Analyst Decision
- VMEO Buy
- AORT Strong Buy
- Analyst Count
- VMEO 4
- AORT 6
- Target Price
- VMEO $7.35
- AORT $32.00
- AVG Volume (30 Days)
- VMEO 1.7M
- AORT 327.6K
- Earning Date
- VMEO 08-04-2025
- AORT 08-07-2025
- Dividend Yield
- VMEO N/A
- AORT N/A
- EPS Growth
- VMEO N/A
- AORT N/A
- EPS
- VMEO 0.10
- AORT N/A
- Revenue
- VMEO $415,130,000.00
- AORT $390,084,000.00
- Revenue This Year
- VMEO $3.90
- AORT $12.18
- Revenue Next Year
- VMEO $6.17
- AORT $10.39
- P/E Ratio
- VMEO $38.51
- AORT N/A
- Revenue Growth
- VMEO N/A
- AORT 5.94
- 52 Week Low
- VMEO $3.45
- AORT $21.97
- 52 Week High
- VMEO $7.90
- AORT $32.33
- Technical
- Relative Strength Index (RSI)
- VMEO 31.72
- AORT 63.28
- Support Level
- VMEO $3.85
- AORT $30.32
- Resistance Level
- VMEO $4.08
- AORT $31.66
- Average True Range (ATR)
- VMEO 0.12
- AORT 0.68
- MACD
- VMEO 0.00
- AORT 0.02
- Stochastic Oscillator
- VMEO 12.07
- AORT 76.79
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.